Engineered high-affinity dual targeting cellular nanovesicles for optimized cancer immunotherapyLuyao Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Jie Ma(Beijing Hospital)Research SquareJanuary 10, 202310.21203/rs.3.rs-2434262/v1Cited by 0SaveCiteExport RISWatch citationsRelated PapersBEST1 Positive Monocytes in Circulation: Visualize Intratumoral Crosstalk between Cancer Cells and Monocytes|Advanced Science|2023|7Identification of MORF4L1 as an endogenous substrate of CRBN and its potential role as a therapeutic target in cancer|Scientific Reports|2025|6